In conclusion, the PcActx peptide functions as a TRPV1 modulator of intercellular calcium homeostasis, inhibits ATD-like amyloid neuropathology through Akt/Gsk3-mediated NRF2 activation, and represents a potential alternative agent for the treatment of ATD.62 Here, TRPV1 is linked to Jeune syndrome.